NorthWest Biotherapeutics Inc (NWBO)

[HappyLibrarian]

The "some reason" you mentioned is in large part because the NASDAQ took a lot of the sweetness out of the deal for Cognate, which used to get MFN status including anti-dilution protection, things none of us get.

Ms. Powers has obligations to Cognate stakeholders too, and now buying NWBO is as risky for them as it has ALWAYS been for us.

So you raise a decent point as far as it goes.

But if we get indisputably positive news, these problems go away overnight.

I am less negative about things because the true issue with this company - lack of transparency - seems about to go away.

Now if September 30, 2016 comes and goes without a real update, then you will be right.